Brief: Orchid Pharma Gets U.S. FDA Nod For ANDA For Aripiprazole Orally Disintegrating Tablets
13/12/2017 07:56
Dec 13 (Reuters) - Orchid Pharma Ltd ORCD.NS :
* SAYS GETS ANDA APPROVAL FROM U.S. FDA FOR ARIPIPRAZOLE
ORALLY
DISINTEGRATING TABLETS
Source text - http://bit.ly/2BiJ7v9
Further company coverage: ORCD.NS
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Orchid Pharma
See all newsBrief: Orchid Pharma Approves Enabling Resolution To Explore Fund Raising Via Equity Or Other Securities
Brief: Orchid Pharma To Consider And Evaluate Various Options For Raising Funds
Brief: Orchid Pharma June-Quarter Consol Profit 25.8 Million Rupees
India's Orchid Pharma jumps on pact to commercialize Exblifep in Russia
Refile: INDIA STOCKS-Indian shares set to open lower as US-Iran tensions lift oil prices